Miho Yano

435 citations
10 papers · 342 indexed · h-index 7
Topics
Diabetes Treatment and Management (2 papers)Advanced Glycation End Products research (2 papers)Atherosclerosis and Cardiovascular Diseases (2 papers)
Journals
SHILAP Revista de lepidopterologíaDiabetes CareDiabetic Medicine
Partner nations
Japan

In The Last Decade

Miho Yano

10 papers receiving 331 citations

Peers

Miho Yano
Comparison fields: 5 of 77
  • Epidemiology 83
  • Immunology 72
  • Molecular Biology 71
  • Endocrinology, Diabetes and Metabolism 62
  • Physiology 48
Replace G Capretti with:
G Capretti Italy
Seijiro Kado Japan
Mahendra Prasad Bhatt South Korea
Hitoshi Omi Japan
Peter Fitzgerald France
Gurinder Bir Singh India
Sayu Omori Japan
Chie Kawahara Japan
Tomoe Kinoshita Japan
Miho Yano relative to G Capretti Italy G Capretti's profile →
Citations per field
00.5×1.5×
G Capretti · 1×
Citations per year

Countries citing papers authored by Miho Yano

Since Specialization
Citations

This map shows the geographic impact of Miho Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Yano more than expected).

Fields of papers citing papers by Miho Yano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Yano. The network helps show where Miho Yano may publish in the future.

Co-authorship network of co-authors of Miho Yano

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Yano. A scholar is included among the top collaborators of Miho Yano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Yano. Miho Yano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 2
3 17
4 28
5 71
6 49
7 15
8 106
9
[A case of primary pulmonary proteinosis with bilateral pneumothorax].
2
10 46

About Miho Yano

Miho Yano is a scholar working on Clinical Biochemistry, Immunology and Allergy and Urology, having authored 10 papers that have together received 342 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (2 papers), Advanced Glycation End Products research (2 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). The work is most often cited by research in Clinical Biochemistry (33 citations), Endocrinology, Diabetes and Metabolism (62 citations) and Immunology (72 citations). Miho Yano has collaborated with scholars based in Japan. Frequent co-authors include Goji Hasegawa, Michiyo Ishii, Takeo Yoshikawa, Naoto Nakamura, Hiroshi Obayashi, A. Kitamura, Masahiro Yamasaki, Naoto Nakamura, Michiaki Fukui and Toshikazu Yoshikawa. Their work appears in journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetic Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026